Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Pharscin Pharma(002907) the Revenue is 201.7 M (-0.62%);the EBIT is 35.91 M (+512.2%);the EPS is 0.0723 (+122%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.20B0.62%
----
----
EBIT
0.04B512.19%
----
----
EPS
0.0723121.97%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf